R. Lamerz et al., Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions, ANTICANC R, 19(4A), 1999, pp. 2421-2425
Human chorionic gonadotropin (HCG) is expressed in germ cell tumors and uro
thelial, breast, lung and colon cancers. The aim of the study was to invest
igate if the determination of HCG in comparison with CEA is able to discrim
inate between malignant and benign effusions. Effusion and partially serum
samples of 61 patients with benign (g.i., heart/kidney isnuff.) and 116 pat
ients with malignant diseases (g.i., gynec., lung, misc., CUP) were investi
gated HCG; was specifically determined by an IRMA using 2 monoclonal antibo
dies, CEA by a conventional double Ab RIA. Cytological staining was preform
ed using the Pappenheim-method on cytospin preparations. Significant differ
ences (p<0.001) were found for HCG between benign and malignant ascitic eff
usions with the best discrimination at 5 IU/l (ROC) and an overall sensitiv
ity of 31.3% (spec. vs benign eff 93.4%) increasing in subgroups from hemat
ol. (5.8%) <misc. (31.3%) <gynec. (32.1%) <g.i. (36%) < lung (38.1%) to CUP
(50%). CEA also showed significant differences between benign and malignan
t total and ascitic effusions, and weaker for the pleural subgroup (cutoff
9 ng/ml) with a total sensitivity of 44.6% (sp=100%) increasing from misc.
(30.8%) <lung (47.1%) <CUP (50%) < gynec. (60%) <g.i. (60.9%). Comparative
cytology and TM determinations increased the positiverate of cytology (45.2
%) to 58.3% for either cytology or HCG positive cases, or to 61.6% for eith
er cytology or CEA positive cases. For the combined determination of cytolo
goy and HCG and CEA, the overall TM positive rate for 33 cytology-pos. case
s was 78.8%, but in 40 cytology-negative cases 37.5% for TM positive cases.
in conclusion HCG is useful in ascitic > pleural effusions with high speci
ficity (90% at 5 IU/l) but low sensitivity of 31% increasing in g.i., lung
and gynecologic cases, CEA a more general TM with higher sensitivity of 45%
increasing in g.i., gynecologic and lung cases (sp. 100% at 9 ng/ml) both
adding significantly to cytology-negative effusions.